COLOALERT
LIVE

Serial Number

97375172

Owner

Mainz Biomed N.V.

Attorney

Eric R. Moran

Filing Date

Apr 21, 2022

Add to watchlist:

No watchlists yet
View on USPTO

COLOALERT Trademark

Serial Number: 97375172 • Registration: 8045573

COLOALERT is a trademark filed by Mainz Biomed N.V. on April 21, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Mainz Biomed N.V. (3 trademarks)

GutenbergPark, Robert-Koch-Str. 50
Mainz 55129 , DE

Entity Type: 99

Trademark Details

Filing Date

April 21, 2022

Registration Date

December 2, 2025

Published for Opposition

October 14, 2025

Goods & Services

Medical diagnostic apparatus for testing cancer cells; Medical diagnostic apparatus for testing for cancer, colorectal cancer for medical purposes; Diagnostic apparatus for testing for cancer, colorectal cancer for medical purposes; Diagnostic measuring apparatus for medical use for measuring biological samples; Tools for medical diagnostics for the analysis of biological samples; Medical diagnostic apparatus for analysing substances for detecting cancer, colorectal cancer; Medical analytical apparatus for medical purposes for testing for cancer, colorectal cancer; Genetic testing apparatus for medical purposes; Medical diagnostic apparatus for medical purposes for testing for cancer, colorectal cancer; Measuring devices for medical use for measuring biological samples; Specimen samplers for medical use, namely, medical specimen collection devices in the nature of containers for the collection of biological samples; Apparatus for medical cell sampling

Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; DNA screening for medical purposes; RNA or DNA analysis services for the diagnosis and prognosis of diseases; Genetic counseling; Medical and healthcare services relating to DNA, genetics and genetic testing; Genetic testing for medical purposes; Genetic testing of animals for diagnostic or treatment purposes

Chemically treated papers for use in the detection of fecal occult blood; Chemical preparations for use in DNA analysis for medical purposes; Diagnostic preparations for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic agents for pharmaceutical use; Diagnostic preparations for veterinary purposes; Diagnostic biomarker reagents for medical purposes; In vitro diagnostic preparations for medical use; Medical diagnostic test strips for blood analysis; Medical diagnostic reagents and assays for testing of body fluids and excreta; Preparations for detecting genetic predispositions for medical purposes; Reagents for analytical purposes for medical purposes; Reagents for in-vitro laboratory use for medical purposes; Reagents and media for medical and veterinary diagnostic purposes; Reagents for use in analysis for medical purposes; Reagents for use in diagnostic tests for medical purposes; Reagents for use in medical genetic testing; Reagents for medical use; Reagents for use in veterinary genetic testing; Diagnostic preparations and materials for medical purposes; Diagnostic test kits comprised of medical diagnostic reagents and assays for the detection of diseases, namely, cancer, colorectal cancer

Biological research; Computer software design for others; Research and development of new products for others; Installation of computer software; Software as a service (SAAS) services featuring software for database management, electronic storage of data, data processing; Technological consultancy services in the medical field; Rental of computers and computer software for database management, electronic storage of data, data processing; Scientific research; Scientific laboratory services

Downloadable and recorded electronic databases for use in the medical field; Data sets, recorded or downloadable, for use in the medical field; Downloadable and recorded computer software for data processing; Downloadable and recorded computer software for use in database management, electronic storage of data, data processing, relating to the medical field; Downloadable and recorded computer software to enable the searching of data; Downloadable and recorded computer software for use in medical decision support systems for database management, electronic storage of data, data processing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 2, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 2, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Oct 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 18, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 18, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 18, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 18, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2025 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sep 17, 2025 ERSI
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jun 30, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jun 30, 2025 XELR
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 30, 2025 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 30, 2025 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 30, 2025 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 10, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jul 17, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Jul 17, 2024 GNSL
SUSPENSION LETTER WRITTEN
Jul 17, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 17, 2024 CRFA
ASSIGNED TO LIE
Jul 17, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 7, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 5, 2023 DOCK
ASSIGNED TO EXAMINER
Sep 5, 2023 DOCK
ASSIGNED TO EXAMINER
Aug 28, 2023 DOCK
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 8, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 8, 2023 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 12, 2023 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 12, 2023 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 16, 2023 GNRN
NON-FINAL ACTION E-MAILED
Feb 16, 2023 GNRT
NON-FINAL ACTION WRITTEN
Feb 16, 2023 CNRT
ASSIGNED TO EXAMINER
Feb 8, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 27, 2022 NWOS
NEW APPLICATION ENTERED
Apr 25, 2022 NWAP